| Methods |
Blinding of randomisation: no
Blinding of intervention: can't tell but probably impossible
Complete follow‐up: no
Blinding of outcome measurement: can't tell |
| Participants |
Term infants, >2500g.
Infants with haemolysis, contained haemorrhage, infection, congenital malformations excluded.
Qualifying SBR >220 up to 72 hours, and >255 after 72 hours.
Fibreoptic n=50, conventional n=50. |
| Interventions |
Fibreoptic: Wallaby at 9.2 microwatts per cm2/nm (measured).
Conventional: Ohio at 18.4 microwatts/cm2/nm (measured, 5 special blue lamps). |
| Outcomes |
Duration of phototherapy.
Absolute change in SBR/hr over treatment period.
% change in SBR/hr over treatment period.
Failure of treatment. |
| Notes |
Author unable to be contacted |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
High risk |
C ‐ Inadequate |
